Tenax Therapeutics director Declan Doogan buys 53,000 shares worth $101,760
TENX•Director share purchase and holdings
- Tenax Therapeutics director Declan Doogan bought 53,000 common shares at USD 1.92, lifting direct holdings to 55,274 shares.
- Doogan also reported stock options covering 210,008 shares, with exercise prices ranging from USD 5.75 to USD 3,200.
